Eric Schwartz - Globus Medical Senior Vice President General Counsel

GMED Stock  USD 53.64  0.58  1.09%   

President

Mr. Eric I. Schwartz is no longer Senior Vice President, General Counsel of the Company effective November 2, 2018. Prior to joining Globus Medical, Mr. Schwartz was a Member in the corporate practice of Cozen OConnor, a law firm based in Philadelphia. Before joining Cozen OConnor, Mr. Schwartz spent two years as Chief Operating Officer of CardioVIP, Inc., a venturebacked health care services company based in Sugar Land, Texas. He previously served as Executive Vice President and Chief Legal Officer of ERT, Inc., a Philadelphiabased provider of medical devices and research services to the biopharmaceutical industry. Prior to ERT, Mr. Schwartz spent 5 years at Johnson Johnson, serving as Assistant General Counsel and supporting several highgrowth businesses within the companys medical devices division, including Animas Corporation and Ethicon Biosurgery. He had been Vice President and General Counsel of Animas prior to its acquisition by Johnson Johnson in 2006. Eric began his legal career as an associate at the law firms Skadden, Arps, Slate, Meagher Flom LLP in New York and Dechert LLP in Philadelphia
Age 48
Professional MarksMBA
Phone610 930 1800
Webhttps://www.globusmedical.com
Schwartz received his B.A. and J.D. from the University of Virginia and holds an MBA in Finance with honors from the Wharton School of Business at the University of Pennsylvania.

Globus Medical Management Efficiency

The company has return on total asset (ROA) of 0.0477 % which means that it generated a profit of $0.0477 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0421 %, meaning that it created $0.0421 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 520.4 M in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Globus Medical has a current ratio of 5.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Globus Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Globus Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Globus Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Globus to invest in growth at high rates of return. When we think about Globus Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Kristen LauriaCigna Corp
51
Matt PerlbergCigna Corp
N/A
Mark BoxerCigna Corp
59
Sandra VaartLaboratory
64
Lisa BacusCigna Corp
53
Michael PhillipsCigna Corp
N/A
Charles LynchMednax Inc
N/A
AmirAli TalasazGuardant Health
44
Marcel RocheGuardant Health
N/A
Eric PalmerCigna Corp
48
MICHAEL TRIPLETTCigna Corp
59
Adam PharmDCigna Corp
N/A
Scott FrommerLaboratory
N/A
Everett NevilleCigna Corp
59
Christopher MBACigna Corp
N/A
Brian CaveneyLaboratory
47
Brian EvankoCigna Corp
47
William KlitgaardLaboratory
61
Stephen FarberMednax Inc
49
Michael StanleyMednax Inc
68
Herbert FritchCigna Corp
64
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. Globus Medical (GMED) is traded on New York Stock Exchange in USA. It is located in 2560 General Armistead Avenue, Audubon, PA, United States, 19403 and employs 5,000 people. Globus Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Globus Medical Leadership Team

Elected by the shareholders, the Globus Medical's board of directors comprises two types of representatives: Globus Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Globus. The board's role is to monitor Globus Medical's management team and ensure that shareholders' interests are well served. Globus Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Globus Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steve Zarrilli, Independent Director
David Paul, Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee
Eric Schwartz, Senior Vice President General Counsel
Mike Reeder, Ex Officer
Ann Rhoads, Independent Director
Robert Douglas, Independent Director
Andrew Murphy, Group President Commercial Operations
Steven Payne, VP Controller
Anthony Williams, Senior Vice President General Counsel
Kelly Esq, General VP
Kelly Huller, Senior Vice President General Counsel, Corporate Secretary
Stephen Zarrilli, Independent Director
Robert Liptak, Independent Director
James Tobin, Independent Director
Kurt Wheeler, Independent Director
Brian Kearns, Senior Relations
Brett Murphy, Group President of Commercial Operations
Richard Holifield, Ex Officer
Daniel Lemaitre, Independent Director
John Dowling, Ex Officer
Keith Pfeil, Chief Financial Officer, Senior Vice President
David Demski, Group President of Emerging Technologies, Director and Member of Nominating and Corporate Governance Committee
Daniel Scavilla, Executive Vice President, Chief Commercial Officer and President - Trauma
David Davidar, Co-Founder, Sr. VP of Operations and Director

Globus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Globus Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.